三叶草生物制药有限公司（股票代码：02197）于2026年3月5日发布截至2026年2月28日的月度证券变动情况。公告显示，公司注册股本维持在2,000,000,000股，面值每股USD 0.0001，合计USD 200,000，与上月保持一致。
公司本月末已发行股份总数为1,298,037,427股，与上月底持平。本月内未见任何新增发行、股份购回或注销活动，库藏股份数量仍为零，未发生变化。
根据公告，公司授予的首次公开发售前购股权和首次公开发售后购股权计划在当月无新增授出、行使、失效或取消，合计已授出但未行使的股份期权数量分别为1,506,817股及32,655,480股，未发生变动。
公告亦确认公司遵守了香港联合交易所有限公司《上市规则》及相关法律规定，本月相关证券事项均获得公司董事会正式授权批准。公告由公司董事梁朋签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.